Conference Proceedings

DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma—First results.

Anna K Nowak, Willem Joost Lesterhuis, Brett Gordon Maxwell Hughes, Chris Brown, Peey Sei Kok, Kenneth John O'Byrne, Tom John, Nick Pavlakis, Steven Chuan-Hao Kao, Sonia Yip, Deme John Karikios, Wei-Sen Lam, Ailsa Langford, Martin R Stockler

Journal of Clinical Oncology | American Society of Clinical Oncology (ASCO) | Published : 2018

Citation metrics